title: An analysis of the HumaPen Luxura HD pen: what is the role of 0.5-unit insulin dosing?
authors.affiliation: Division of Endocrinology, Diabetes, and Bone Disease, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA. magnottimd@yahoo.com
authors.forename: Michael A
authors.initials: MA
authors.lastname: Magnotti
authors.forename: Elliot J
authors.initials: EJ
authors.lastname: Rayfield
mesh_terms: D000328:Adult; D017028:Caregivers; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007003:Hypoglycemia / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use*; D012648:Self Care; D012680:Sensitivity and Specificity
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin